Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AEON Biopharma, Inc. | 308,641 | reported | 21 May 2025 | tx 5+515,983 |
| ENDOLOGIX INC /DE/ | 17,143 | reported | 19 Oct 2015 | tx 12+180,627−41,863 |
| Venus Concept Inc. | 13,708 | reported | 13 Jun 2018 | tx 1+13,708 |
| LENZ Therapeutics, Inc. | 13,500 | reported | 11 Jun 2025 | tx 2+40,500 |
| INTRALASE CORP | 0 | reported | 02 Apr 2007 | tx 94+95,467−388,552 |
| RxSight, Inc. | 0 | reported | 14 Apr 2025 | tx 59+653,283−347,643 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2025 | GRANT_AWARD | LENZ Therapeutics, Inc. | 13,500 | 0.00 USD | deriv |
| 21 May 2025 | GRANT_AWARD | AEON Biopharma, Inc. | 308,641 | 0.00 USD | deriv |
| 14 Apr 2025 | EXERCISE | RxSight, Inc. | 7,792 | 4.34 USD | |
| 14 Apr 2025 | EXERCISE | RxSight, Inc. | 6,405 | 0.00 USD | deriv |
| 14 Apr 2025 | EXERCISE | RxSight, Inc. | 1,387 | 0.00 USD | deriv |
| 27 Feb 2025 | GRANT_AWARD | RxSight, Inc. | 125,000 | 0.00 USD | deriv |
| 01 Oct 2024 | SALE | RxSight, Inc. | 278 | 49.45 USD | |
| 01 Oct 2024 | SALE | RxSight, Inc. | 9,521 | 48.69 USD | |
| 01 Oct 2024 | EXERCISE | RxSight, Inc. | 15,000 | 16.00 USD | |
| 01 Oct 2024 | SALE | RxSight, Inc. | 5,201 | 47.96 USD | |
| 01 Oct 2024 | EXERCISE | RxSight, Inc. | 15,000 | 0.00 USD | deriv |
| 31 Aug 2024 | GRANT_AWARD | AEON Biopharma, Inc. | 36,021 | 0.00 USD | |
| 31 Aug 2024 | GRANT_AWARD | AEON Biopharma, Inc. | 96,210 | 0.00 USD | deriv |
| 07 Aug 2024 | GRANT_AWARD | RxSight, Inc. | 50,000 | 0.00 USD | deriv |
| 15 Jul 2024 | EXERCISE | RxSight, Inc. | 16,505 | 4.34 USD | |
| 15 Jul 2024 | EXERCISE | RxSight, Inc. | 5,270 | 0.00 USD | deriv |
| 15 Jul 2024 | EXERCISE | RxSight, Inc. | 11,235 | 0.00 USD | deriv |
| 01 Jul 2024 | SALE | RxSight, Inc. | 8,146 | 58.41 USD | |
| 01 Jul 2024 | SALE | RxSight, Inc. | 1,854 | 59.48 USD | |
| 01 Jul 2024 | SALE | RxSight, Inc. | 6,599 | 58.55 USD | |
| 01 Jul 2024 | SALE | RxSight, Inc. | 1,803 | 59.56 USD | |
| 01 Jul 2024 | EXERCISE | RxSight, Inc. | 10,000 | 15.60 USD | |
| 01 Jul 2024 | EXERCISE | RxSight, Inc. | 10,000 | 0.00 USD | deriv |
| 01 May 2024 | EXERCISE | RxSight, Inc. | 10,247 | 15.60 USD | |
| 01 May 2024 | SALE | RxSight, Inc. | 9,620 | 52.68 USD |